Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Maria Pilar Lobera has a total of 28 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A double-redox aqueous capacitor with high energy output

    by Adam Slesinski, Sylwia Sroka, Sergio Aina, Justyna Piwek, Krzysztof Fic, M. Pilar Lobera, Maria Bernechea, Elzbieta Frackowiak

    The paper puts forward the concept of a double-redox electrochemical capacitor operating in an aqueous electrolyte. The redox activity of sulphur from insoluble Bi2S3 nanocrystals embedded in the negative electrode material (up to 10 wt%) operating in 1 mol L−1 Li2SO4 electrolyte is demonstrated. It is also shown that the performance is significantly boosted using MPA (3-mercaptopropionic acid) as a ligand attached to the surface of the nanocrystals, which allows for more efficient use of Bi2S3 redox active species. This redox activity is combined with the reactions of iodides, which occur at the opposite electrode with 1 mol L−1 NaI. This enables the formation of a discharge voltage plateau that effectively boosts the capacitance (275 F g−1), and thus specific energy of the device owing to the relatively high cell voltage of 1.5 V. This performance is possible due to the advantageous electrode mass ratio (m− : m+ = 2 : 1), which helps to balance the charge. The rate capability test of the device demonstrates its capacitance retention of 73% at 10 A g−1 of the discharge current. The different states of the redox species ensure their operation at separate electrodes in an immiscible manner without a shuttling effect. The specific interactions of the redox active species with carbon electrodes are supported by operando Raman spectroscopy.


  • Open Access

    Engineering Alginate-Based Dry Powder Microparticles to a Size Suitable for the Direct Pulmonary Delivery of Antibiotics

    by Beatriz Arauzo, Álvaro González-Garcinuño, Antonio Tabernero, Javier Calzada-Funes, María Pilar Lobera, Eva M. Martín del Valle, Jesus Santamaria

    The inhaled route is regarded as one of the most promising strategies as a treatment against pulmonary infections. However, the delivery of drugs in a dry powder form remains challenging. In this work, we have used alginate to form microparticles containing an antibiotic model (colistin sulfate). The alginate microparticles were generated by atomization technique, and they were characterized by antimicrobial in vitro studies against Pseudomonas aeruginosa. Optimization of different parameters allowed us to obtain microparticles as a dry powder with a mean size (Feret diameter) of 4.45 ± 1.40 µm and drug loading of 8.5 ± 1.50%. The process developed was able to concentrate most of the colistin deposits on the surface of the microparticles, which could be observed by SEM and a Dual-Beam microscope. This produces a fast in vitro release of the drug, with a 100% release achieved in 4 h. Physicochemical characterization using the FTIR, EDX and PXRD techniques revealed information about the change that occurs from the amorphous to a crystalline form of colistin. Finally, the cytotoxicity of microparticles was tested using lung cell lines (A549 and Calu-3). Results of the study showed that alginate microparticles were able to inhibit bacterial growth while displaying non-toxicity toward lung cells.


  • Open Access

    Tuning Alginate Microparticle Size via Atomization of Non-Newtonian Fluids

    by Beatriz Arauzo, Álvaro González-Garcinuño, Antonio Tabernero, Maria Pilar Lobera, Jesus Santamaria, Eva María Martín del Valle

    A new approach based on the atomization of non-Newtonian fluids has been proposed to produce microparticles for a potential inhalation route. In particular, different solutions of alginate were atomized on baths of different crosslinkers, piperazine and barium chloride, obtaining microparticles around 5 and 40 microns, respectively. These results were explained as a consequence of the different viscoelastic properties, since oscillatory analysis indicated that the formed hydrogel beads with barium chloride had a higher storage modulus (1000 Pa) than the piperazine ones (20 Pa). Pressure ratio (polymer solution-air) was identified as a key factor, and it should be from 0.85 to 1.00 to ensure a successful atomization, obtaining the smallest particle size at intermediate pressures. Finally, a numerical study based on dimensionless numbers was performed to predict particle size depending on the conditions. These results highlight that it is possible to control the microparticles size by modifying either the viscoelasticity of the hydrogel or the experimental conditions of atomization. Some experimental conditions (using piperazine) reduce the particle size up to 5 microns and therefore allow their use by aerosol inhalation.


  • Open Access

    Excipient-Free Inhalable Microparticles of Azithromycin Produced by Electrospray: A Novel Approach to Direct Pulmonary Delivery of Antibiotics

    by Beatriz Arauzo, Tania B. Lopez-Mendez, Maria Pilar Lobera, Javier Calzada-Funes, Jose Luis Pedraz, Jesus Santamaria

    Inhalation therapy offers several advantages in respiratory disease treatment. Azithromycin is a macrolide antibiotic with poor solubility and bioavailability but with a high potential to be used to fight lung infections. The main objective of this study was to generate a new inhalable dry powder azithromycin formulation. To this end, an electrospray was used, yielding a particle size around 2.5 µm, which is considered suitable to achieve total deposition in the respiratory system. The physicochemical properties and morphology of the obtained microparticles were analysed with a battery of characterization techniques. In vitro deposition assays were evaluated after aerosolization of the powder at constant flow rate (100 L/min) and the consideration of the simulation of two different realistic breathing profiles (healthy and chronic obstructive pulmonary disease (COPD) patients) into a next generation impactor (NGI). The formulation was effective in vitro against two types of bacteria, Staphylococcus aureus and Pseudomonas aeruginosa. Finally, the particles were biocompatible, as evidenced by tests on the alveolar cell line (A549) and bronchial cell line (Calu-3).


  • Bismuth-based nanomaterials for energy applications

    by Nichole C. Cates, Jessica C. Ramirez de la Torre, Sergio Aina, M. Pilar Lobera, María Bernechea


  • Open Access

    Modeling the size distribution in a fluidized bed of nanopowder

    by Andrea Fabre, Alberto Clemente, Francisco Balas, M. Pilar Lobera, Jesús Santamaría, Michiel T. Kreutzer, J. Ruud van Ommen

    The release of nanosized particles from fluidized beds of ceramic oxide nanopowders, namely, TiO2(P25), Al2O3(AluC) and SiO2(A130) has been assessed for the first time.